5 semaglutide / Cyanocobalamin Injection Compounded Semaglutide - LaSara Medical

Dosing decisions respond to objective diagnostic data, not standardized escalation schedules

This method of appetite control helps to ensure that weight loss is manageable over the long term, without the risk of rebound hunger that many other medications cause

Weight-Related Health Conditions May Include: Type 2 diabetes or prediabetes High blood pressure (hypertension) High cholesterol or dyslipidemia Obstructive sleep apnea Cardiovascular disease risk factors Joint problems related to excess weight Fatty liver disease Age Requirements: Patients must be 18 years of age or older to use the Refills Health platform

Clinical trial data from SURMOUNT-1 shows that the 2.5 mg dose produces minimal weight reduction on its own, which is expected since this dose is specifically labeled as an initiation dose rather than a maintenance dose

More importantly, it drove action